Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00599040 · ClinicalTrials.gov registry record · Phase 4
The DINE Study-Diet Intervention to Negate Diabetes Study (Improving Weight Loss Outcomes for African Americans)
A Phase 4 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 4
- Development phase
- 113
- Enrollment target
NCT00599040: Completed Phase 4 study, sponsored by University of Alabama at Birmingham.
NCT00599040 is a Phase 4 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 113 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00599040, a Phase 4 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 113 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if what you eat affets your insulin sensitivity when you lose a small amount of weight
Interventions
- BEHAVIORAL The DASH diet with weight loss
- BEHAVIORAL The DASH diet without weight loss
- BEHAVIORAL Dairy diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2005-09 |
| Est. Completion | 2010-12 |
| Phase | Phase 4 |
What the finished NCT00599040 record still lists
NCT00599040 is an interventional study that assigns participants to a tested intervention. The registered 113 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 3 interventions - of which The DASH diet with weight loss is the first listed.
NCT00599040 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00599040 about?
NCT00599040 is a clinical study titled "The DINE Study-Diet Intervention to Negate Diabetes Study (Improving Weight Loss Outcomes for African Americans)". The purpose of this study is to determine if what you eat affets your insulin sensitivity when you lose a small amount of weight
What is the current status of trial NCT00599040?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 113 participants. The study started on 2005-09. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00599040?
The interventions under investigation include: The DASH diet with weight loss (BEHAVIORAL), The DASH diet without weight loss (BEHAVIORAL), Dairy diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT00599040?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00599040's enrollment target sits among peer trials
113 723rd of 2000 higher than 1,277 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00748254 · 113 participants
Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis
- NCT04753190 · 113 participants · NA
Light Timing Study
- NCT05799248 · 113 participants · Phase 3
Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management
- NCT07216105 · 113 participants · Phase 1
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia